Senseonics Holdings, Inc. (SENS)
USD 0.71
(-1.81%)
USD 0.71
(-1.81%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -75.6 Million USD | -10.17% |
| 2022 | -68.62 Million USD | -20.02% |
| 2021 | -57.18 Million USD | 27.74% |
| 2020 | -79.13 Million USD | 39.44% |
| 2019 | -130.66 Million USD | -49.2% |
| 2018 | -87.57 Million USD | -55.52% |
| 2017 | -56.31 Million USD | -32.71% |
| 2016 | -42.43 Million USD | -47.28% |
| 2015 | -28.81 Million USD | -54.06% |
| 2014 | -18.7 Million USD | 0.46% |
| 2013 | -18.78 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -75.6 Million USD | -10.17% |
| 2023 Q1 | -19.02 Million USD | 4.26% |
| 2023 Q4 | -19.49 Million USD | -6.92% |
| 2023 Q3 | -18.23 Million USD | -7.22% |
| 2023 Q2 | -17 Million USD | 10.61% |
| 2022 Q2 | -18.86 Million USD | -7.35% |
| 2022 Q3 | -19.7 Million USD | -4.5% |
| 2022 Q4 | -19.86 Million USD | -0.81% |
| 2022 Q1 | -17.56 Million USD | -3.13% |
| 2022 FY | -68.62 Million USD | -20.02% |
| 2021 Q3 | -15.16 Million USD | -8.71% |
| 2021 Q2 | -13.94 Million USD | 13.01% |
| 2021 Q4 | -17.03 Million USD | -12.37% |
| 2021 Q1 | -16.03 Million USD | -0.89% |
| 2021 FY | -57.18 Million USD | 27.74% |
| 2020 Q1 | -12.46 Million USD | 0.46% |
| 2020 Q4 | -15.89 Million USD | -40.42% |
| 2020 FY | -79.13 Million USD | 39.44% |
| 2020 Q2 | -10.3 Million USD | 17.34% |
| 2020 Q3 | -11.31 Million USD | -9.8% |
| 2019 Q1 | -31.36 Million USD | 9.49% |
| 2019 FY | -130.66 Million USD | -49.2% |
| 2019 Q4 | -12.52 Million USD | 71.42% |
| 2019 Q3 | -43.83 Million USD | -25.67% |
| 2019 Q2 | -34.87 Million USD | -11.2% |
| 2018 Q2 | -28.61 Million USD | -24.54% |
| 2018 Q1 | -22.97 Million USD | -14.51% |
| 2018 Q3 | -29.76 Million USD | -4.04% |
| 2018 Q4 | -34.65 Million USD | -16.41% |
| 2018 FY | -87.57 Million USD | -55.52% |
| 2017 Q3 | -15.92 Million USD | -1.64% |
| 2017 FY | -56.31 Million USD | -32.71% |
| 2017 Q4 | -20.06 Million USD | -25.97% |
| 2017 Q2 | -15.67 Million USD | 5.63% |
| 2017 Q1 | -16.6 Million USD | -42.64% |
| 2016 Q2 | -9.44 Million USD | 10.18% |
| 2016 Q1 | -10.51 Million USD | 8.99% |
| 2016 Q3 | -12.39 Million USD | -31.3% |
| 2016 Q4 | -11.64 Million USD | 6.1% |
| 2016 FY | -42.43 Million USD | -47.28% |
| 2015 FY | -28.81 Million USD | -54.06% |
| 2015 Q1 | -1759.00 USD | 95.78% |
| 2015 Q2 | -8.18 Million USD | -465448.61% |
| 2015 Q3 | -10.92 Million USD | -33.45% |
| 2015 Q4 | -11.55 Million USD | -5.69% |
| 2014 FY | -18.7 Million USD | 0.46% |
| 2014 Q3 | -1659.00 USD | 36.94% |
| 2014 Q4 | -41.64 Thousand USD | -2410.37% |
| 2014 Q1 | -21.65 Thousand USD | 0.0% |
| 2014 Q2 | -2631.00 USD | 87.85% |
| 2013 FY | -18.78 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | -15.18 Million USD | -397.978% |
| Electromed, Inc. | 6.58 Million USD | 1248.807% |
| Catheter Precision, Inc. | -78.11 Million USD | 3.221% |
| Xtant Medical Holdings, Inc. | -10.15 Million USD | -644.271% |